[go: up one dir, main page]

AR099880A1 - Derivados de nicotinamida como moduladores de trpa1 - Google Patents

Derivados de nicotinamida como moduladores de trpa1

Info

Publication number
AR099880A1
AR099880A1 ARP150100930A ARP150100930A AR099880A1 AR 099880 A1 AR099880 A1 AR 099880A1 AR P150100930 A ARP150100930 A AR P150100930A AR P150100930 A ARP150100930 A AR P150100930A AR 099880 A1 AR099880 A1 AR 099880A1
Authority
AR
Argentina
Prior art keywords
trpa1
nicotinamide derivatives
modulators
trpa1 modulators
cycloalkyl
Prior art date
Application number
ARP150100930A
Other languages
English (en)
Spanish (es)
Inventor
Holm Patrik
Vesalainen Anniina
Arvela Riina
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of AR099880A1 publication Critical patent/AR099880A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
ARP150100930A 2014-03-28 2015-03-27 Derivados de nicotinamida como moduladores de trpa1 AR099880A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20140092 2014-03-28

Publications (1)

Publication Number Publication Date
AR099880A1 true AR099880A1 (es) 2016-08-24

Family

ID=53005579

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100930A AR099880A1 (es) 2014-03-28 2015-03-27 Derivados de nicotinamida como moduladores de trpa1

Country Status (3)

Country Link
AR (1) AR099880A1 (zh)
TW (1) TW201620876A (zh)
WO (1) WO2015144976A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104822653B (zh) * 2012-10-01 2017-03-08 奥赖恩公司 N‑丙‑2‑炔基甲酰胺衍生物及其作为trpa1拮抗剂的用途
CN109952291B (zh) * 2016-09-12 2022-09-23 纽若斯丹公司 与糖尿病相关的神经缺陷的改善
FR3114235A1 (fr) 2020-09-18 2022-03-25 Université Grenoble Alpes Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer
IT202100015098A1 (it) 2021-06-09 2022-12-09 Flonext S R L Composto antagonista del canale trpa1 per uso in patologie degenerative della retina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2723751A1 (en) * 2008-05-05 2009-11-12 Allergan, Inc. Alpha2b and alpha2c agonists
CN104822653B (zh) * 2012-10-01 2017-03-08 奥赖恩公司 N‑丙‑2‑炔基甲酰胺衍生物及其作为trpa1拮抗剂的用途

Also Published As

Publication number Publication date
TW201620876A (zh) 2016-06-16
WO2015144976A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
IL285114B1 (en) Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
CO2017006826A2 (es) Compuestos de picolinamida con actividad fungicida con actividad fungicida
NZ732799A (en) Picolinamides with fungicidal activity
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
MX2017008439A (es) Compuestos de picolinamida con actividad fungicida.
EA201690713A1 (ru) Гетероциклические соединения и их применения
PT3240773T (pt) Compostos picolinamida com atividade fungicida
EA201692105A1 (ru) Новые пиразолопиримидиновые производные и их применение в качестве ингибиторов malt1
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
MX2015017532A (es) Métodos para modular la actividad del regulador de transmembrana de fibrosis quística.
BR112017013062A2 (pt) compostos picolinamida macrocíclicos com atividade fungicida.
MX372740B (es) Derivado de 2,4-diaminopirimidina biciclico fusionado como un inhibidor dual de alk y fak.
EA201790599A1 (ru) Соединения и композиции в качестве ингибиторов киназ
EA201790432A1 (ru) Зонды для визуализации белка хантингтина
LT3191514T (lt) Ligandai, sustiprinantys gonadotropinų biologinį aktyvumą
EA201691412A1 (ru) Гидроксиформамидные производные и их применение
DK3778573T3 (da) Forbindelse med anticanceraktivitet
EP3641758A4 (en) Compounds for the reduction of the deleterious activity of extended nucleotide repeat containing genes
AR099880A1 (es) Derivados de nicotinamida como moduladores de trpa1
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
AR098037A1 (es) Derivados de piperazina y su uso como medicamento
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
IT201700033290A1 (it) “letto migliorato”
UA98922U (ru) 2-((4-амино-5(4-нитро фенил)-1,2,4-триазол-3-ил)тио)ацетонитрил, проявляющая диуретическую активность
UA99044U (ru) (4-амино-3-(децилтио)-1,2,4-триазол-5-ил)(фенил)метанола, проявляющей диуретическую активность

Legal Events

Date Code Title Description
FB Suspension of granting procedure